To validate the antitumor effect of PRMT5 inhibitors in vivo, we also injected PRMT5-knockout Granta-519 into mice and the result confirmed that PRMT5 knockout robustly inhibited the tumor growth (Fig. 5g–i). The gene discussed is PRMT5; the disease is neoplasm.